Nephronophthisis and Senior-Loken syndrome via the NPHP3 Gene
Summary and Pricing 
Test Method
Sequencing and CNV Detection via NextGen Sequencing using PG-Select Capture Probes
| Test Code | Test Copy Genes | Test CPT Code | Gene CPT Codes Copy CPT Code | Base Price | |
|---|---|---|---|---|---|
| 15263 | NPHP3 | 81479 | 81479,81479 | $990 | Order Options and Pricing |
Pricing Comments
Testing run on PG-select capture probes includes CNV analysis for the gene(s) on the panel but does not permit the optional add on of exome-wide CNV analysis. Any of the NGS platforms allow reflex to other clinically relevant genes, up to whole exome or whole genome sequencing depending upon the base platform selected for the initial test.
An additional 25% charge will be applied to STAT orders. STAT orders are prioritized throughout the testing process.
This test is also offered via a custom panel (click here) on our exome or genome backbone which permits the optional add on of exome-wide CNV or genome-wide SV analysis.
Turnaround Time
3 weeks on average for standard orders or 2 weeks on average for STAT orders.
Please note: Once the testing process begins, an Estimated Report Date (ERD) range will be displayed in the portal. This is the most accurate prediction of when your report will be complete and may differ from the average TAT published on our website. About 85% of our tests will be reported within or before the ERD range. We will notify you of significant delays or holds which will impact the ERD. Learn more about turnaround times here.
Targeted Testing
For ordering sequencing of targeted known variants, go to our Targeted Variants page.
Clinical Features and Genetics
Clinical Features
Nephronophthisis (NPH) is the most common genetic cause of progressive renal failure in children and young adults. NPH is characterized by polyuria, growth retardation, and progressive deterioration of renal function with normal or slightly reduced kidney size (Hildebrandt et al. Nat Genet 17:149-153, 1997; Hildebrandt et al. J Am Soc Nephrol 20:23-35, 2009). Nephronophthisis type 3 (NPH3) (OMIM 604387) results in chronic renal failure in adolescents (Omran et al. Am J Hum Genet 66:118-127, 2000; Olbrich et al. Nat Genet 34:455-459, 2003). However, NPH3 has been also reported in five infants before five years of age (Tory et al. Kidney Int 75:839-847, 2009). Of note, a few cases of NPH3 have been associated with tapetoretinal degeneration known as Senior-Loken syndrome (OMIM# 606995) (Bergmann et al. Am J Hum Genet 82:959-970, 2008).
Genetics
NPH3 is inherited in an autosomal recessive manner. Variants in the NPHP3 gene cause NPH3 (Olbrich et al. Nat Genet 34:455-459, 2003). NPHP3 encodes a protein called nephrocystin-3. It has been indicated that nephrocystin-3 interacts with nephrocystin-1 and nephrocystin-4 (products of NPHP1 and NPHP4 genes respectively). Nephrocystin-3 may also have a role in microtubule regulation in monocilia (Olbrich et al. 2003). A mix of nonsense, frameshift, splicing and missense variants have been reported in NPHP3 (Tory et al. Kidney Int 75:839-847, 2009; Olbrich et al. 2003). Nephronophthisis exhibits locus heterogeneity. Nine NPH genes have been identified to date (NPHP1, INVS/NPHP2, NPHP3, NPHP4, IQCB1/NPHP5, CEP260/NPHP6, GLIS2/NPHP7, RPGRIP1L/NPHP8, and NEK8/NPHP9) (Hildebrandt et al. J Am Soc Nephrol 20:23-35, 2009).
Clinical Sensitivity - Sequencing with CNV PG-Select
Variants in NPHP3 gene are estimated to cause approximately ~1% of NPH cases (Hildebrandt et al. J Am Soc Nephrol 20:23-35, 2009).
Testing Strategy
This test is performed using Next-Gen sequencing with additional Sanger sequencing as necessary.
This test provides full coverage of all coding exons of the NPHP3 gene plus 10 bases of flanking noncoding DNA in all available transcripts along with other non-coding regions in which pathogenic variants have been identified at PreventionGenetics or reported elsewhere. We define full coverage as >20X NGS reads or Sanger sequencing.
Indications for Test
Candidates for this test are patients with symptoms consistent with adolescent or juvenile NPH and the family members of patients who have known variants. Conclusive connections between clinical features and individual mutated genes have not yet been made. This test may also be considered for the reproductive partners of individuals who carry pathogenic variants in NPHP3.
Candidates for this test are patients with symptoms consistent with adolescent or juvenile NPH and the family members of patients who have known variants. Conclusive connections between clinical features and individual mutated genes have not yet been made. This test may also be considered for the reproductive partners of individuals who carry pathogenic variants in NPHP3.
Gene
| Official Gene Symbol | OMIM ID |
|---|---|
| NPHP3 | 608002 |
| Inheritance | Abbreviation |
|---|---|
| Autosomal Dominant | AD |
| Autosomal Recessive | AR |
| X-Linked | XL |
| Mitochondrial | MT |
Disease
| Name | Inheritance | OMIM ID |
|---|---|---|
| Adolescent Nephronophthisis | AR | 604387 |
Citations
- Bergmann, C., et.al. (2008). "Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic dysplasia." Am J Hum Genet 82(4): 959-70. PubMed ID: 18371931
- Hildebrandt et al. 1997. PubMed ID: 9326933
- Hildebrandt F. et al. 2009. Journal of the American Society of Nephrology : Jasn. 20: 23-35. PubMed ID: 19118152
- Olbrich, H., et.al. (2003). "Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis." Nat Genet 34(4): 455-9. PubMed ID: 12872122
- Omran, H., et.al. (2000). "Identification of a new gene locus for adolescent nephronophthisis, on chromosome 3q22 in a large Venezuelan pedigree." Am J Hum Genet 66(1): 118-27. PubMed ID: 10631142
- Tory, K., et.al. (2009). "Mutations of NPHP2 and NPHP3 in infantile nephronophthisis." Kidney Int 75(8): 839-47. PubMed ID: 19177160
Ordering/Specimens
Ordering Options
We offer several options when ordering sequencing tests. For more information on these options, see our Ordering Instructions page. To view available options, click on the Order Options button within the test description.
myPrevent - Online Ordering
- The test can be added to your online orders in the Summary and Pricing section.
- Once the test has been added log in to myPrevent to fill out an online requisition form.
- PGnome sequencing panels can be ordered via the myPrevent portal only at this time.
Requisition Form
- A completed requisition form must accompany all specimens.
- Billing information along with specimen and shipping instructions are within the requisition form.
- All testing must be ordered by a qualified healthcare provider.
For Requisition Forms, visit our Forms page
If ordering a Duo or Trio test, the proband and all comparator samples are required to initiate testing. If we do not receive all required samples for the test ordered within 21 days, we will convert the order to the most effective testing strategy with the samples available. Prior authorization and/or billing in place may be impacted by a change in test code.
Specimen Types
Specimen Requirements and Shipping Details
Loading...
×
ORDER OPTIONS
View Ordering Instructions1) Select Test Type
2) Select Additional Test Options
No Additional Test Options are available for this test.